Cost‐Effectiveness of Ivabradine for Heart Failure in the United States

E-ISSN： 2047-9980|5|5|JAHA.116.003221-JAHA.116.003221

ISSN： 2047-9980

Source： JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol.5, Iss.5, 2016-05, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States

By Eckman Mark H. Talal Andrew H. Gordon Stuart C. Schiff Eugene Sherman Kenneth E.

Clinical Infectious Diseases, Vol. 56, Iss. 10, 2013-05 ,pp. : 1382-1393

Oxford University Press

Access to resources Recommend Favorite

Cost‐effectiveness of left ventricular assist devices for patients with end‐stage heart failure: analysis of the French hospital discharge database

ESC HEART FAILURE, Vol. 5, Iss. 1, 2018-02 ,pp. : 75-86

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ivabradine: the start of a SHIFT in heart failure treatment

By Cowie Martin R

Interventional Cardiology, Vol. 5, Iss. 1, 2013-02 ,pp. : 21-31

Future Medicine

Access to resources Recommend Favorite

Compilation of cost-effectiveness evidence for different heart conditions and treatment strategies

By Eckard Nathalie Janzon Magnus Levin Lars-ÅÅke

Scandinavian Cardiovascular Journal, Vol. 45, Iss. 2, 2011-04 ,pp. : 72-76

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness modelling

Human Reproduction, Vol. 16, Iss. 12, 2001-12 ,pp. : 2479-2480

Oxford University Press

Access to resources Recommend Favorite